Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3.
about
Early Defensive Mechanisms against Human Papillomavirus InfectionTherapy of human papillomavirus-related diseaseProgesterone and 17beta-estradiol enhance regulatory responses to human papillomavirus type 16 virus-like particles in peripheral blood mononuclear cells from healthy womenToll-like receptor transcriptome in the HPV-positive cervical cancer microenvironmentSuppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses.IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16/18 vs. non-HPV16/18 genotypes.Immunosuppressive tumor microenvironment in cervical cancer patientsChronic Inflammation-Related HPV: A Driving Force Speeds Oropharyngeal Carcinogenesis.Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation.Peripheral blood lymphocytes from low-grade squamous intraepithelial lesions patients recognize vaccine antigens in the presence of activated dendritic cells, and produced high levels of CD8 + IFNγ + T cells and low levels of IL-2 when induced to prThe immune response to papillomavirus during infection persistence and regression.Immunotherapy of human papilloma virus induced diseaseNew Approaches to Immunotherapy for HPV Associated Cancers.The relation of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV-uninfected women.Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers.Immunologic treatments for precancerous lesions and uterine cervical cancer.Recent progress in vaccination against human papillomavirus-mediated cervical cancer.Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ.Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions.Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.
P2860
Q26852611-D01E0955-FFC7-478D-AF09-558E4BFE675BQ27007473-C4031646-A5B3-4F2D-B60D-19B8E9A0480EQ33768747-8D7BBD25-8D2B-4ED2-B368-8F5CA4C1E816Q34052237-5412ACBC-5267-478B-AA5B-6AB7E07CE6D0Q34408919-1D00C7D0-2C59-4A7F-AD9A-EBAFCCB9B90EQ35049821-DDDDA699-F10D-4197-B2A7-BA6B2D4E4737Q35215727-B1E2282B-21AC-4290-ACF5-237F2353D6F2Q35603131-31124143-4DF2-4D09-9F40-9F86C7ABAB9AQ35699802-A86FE6FE-68AF-4356-9BF3-DE32DB5F8A24Q35962518-ED68BD94-CB50-4839-A8A5-C1A37D6293C7Q36123196-5C923A0F-D713-4427-821B-CA95C1038D6BQ36540399-192816A9-C556-4DB1-88E0-821C437684A8Q36541008-A6358274-E9ED-48B3-82C8-AFE99D432516Q37137430-3D99F2FB-33A3-4BAD-AD67-5ACC3179F2B7Q37577065-C5E8CD44-64A3-4C0A-8506-09E2900B3D50Q37620568-8D2A0771-D1B8-486B-BF97-D30DD2F31E3EQ37703113-2C767BB5-D521-40D8-A82A-4929616A99A6Q38370782-C282E0CA-BC1B-429A-9698-4782D647F514Q42201038-C3FCC7C6-557D-4B98-AC7F-8EFC618A4285Q54937688-8468429C-D756-450E-9476-ACB6C82042C1Q55003290-1A03A9DF-24CC-4691-8B82-472169B006B8
P2860
Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diminished IFN-gamma and IL-10 ...... re associated with CIN 2 or 3.
@en
Diminished IFN-gamma and IL-10 ...... re associated with CIN 2 or 3.
@nl
type
label
Diminished IFN-gamma and IL-10 ...... re associated with CIN 2 or 3.
@en
Diminished IFN-gamma and IL-10 ...... re associated with CIN 2 or 3.
@nl
prefLabel
Diminished IFN-gamma and IL-10 ...... re associated with CIN 2 or 3.
@en
Diminished IFN-gamma and IL-10 ...... re associated with CIN 2 or 3.
@nl
P2093
P2860
P356
P1476
Diminished IFN-gamma and IL-10 ...... re associated with CIN 2 or 3.
@en
P2093
Anna-Barbara Moscicki
Lili Kuzmich
Mark E Scott
P2860
P304
P356
10.1002/IJC.24117
P577
2009-03-01T00:00:00Z